Email
Print
According to the latest market research report on Auto-Injectors Market, published by IndustryARC, The market is expanding as a result of the increased demand for auto-injectors due to novel drug delivery technologies and formulations, as well as advancements in biological pharmaceuticals.
The Auto-Injectors Market research report is segmented By Type (Disposable Auto-Injectors, Reusable Auto-Injectors); By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Others); By End User (Home-care settings, Hospitals & Clinics, Ambulatory Surgical Centers) and By Geography, which provides comprehensive analysis of global market & industry forecast (2024 - 2030).
Request Sample Research Report: https://www.industryarc.com/pdfdownload.php?id=508399
North America Anticipated to Show the Fastest Growth in the Market:
North America is estimated to be the fastest-growing region in the auto-injectors market. The USA auto-injector market has emerged as a critical segment within the healthcare landscape, driven by the increasing prevalence of chronic diseases and allergies and advancements in drug delivery technologies. Approximately 33.1 million Americans suffer from food allergies, according to Food Allergy Research and Education. This includes one in thirteen, or 5.99 million, children under 18. The FDA has to accept new products faster since anaphylaxis and other allergies are more common in the United States. The market is characterized by robust growth, with a rising number of patients seeking self-administration options for conditions such as anaphylaxis, diabetes, and autoimmune diseases.
Auto-Injectors Market 2024-2030: Scope of the Report
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Get Access to the Full Research Report: https://www.industryarc.com/Research/Auto-Injectors-Market-Research-508399
Auto-Injectors Market Report – Key Takeaways:
• Disposable Auto-Injectors is Leading the Market
The Disposable Auto-Injectors segment dominated the auto-injectors market in 2023. The increasing incidence of chronic conditions, such as diabetes, rheumatoid arthritis, and allergies, necessitates the need for self-administered medications, which auto-injectors facilitate. Disposable auto-injectors are designed for user-friendliness, allowing patients to administer medications quickly and easily without needing professional assistance. This convenience is appealing to both patients and healthcare providers.
• Increased Prevalence of Chronic Conditions is Poised to Increase the Auto-Injectors Market Growth
The increased prevalence of chronic conditions such as diabetes, multiple sclerosis, and rheumatoid arthritis is driving the demand for auto-injectors. According to the Centers for Disease Control and Prevention, the United States had 129 million people with at least one major chronic disease by February 2024, with five of the top ten leading causes of death being avoidable and treatable. Over the last two decades, prevalence has risen, with 42.0% having several illnesses. Chronic diseases have a huge impact on the US healthcare system, accounting for 90.0% of the $4.1 trillion spent yearly. As these diseases often require long-term, frequent treatments, there is a growing demand for convenient and reliable self-administration methods, which is projected to accelerate the expansion of the auto-injector market.
• Regulatory Challenges Hinders the Market
The overall market's expansion is projected to be impeded by the industry's stringent regulatory environment for auto-injector approval. Auto-injectors are regulated as combination products by health authorities such as the U.S. FDA and the European Medicines Agency (EMA). This means they must meet both medical device and drug product requirements. Depending on the region, the regulatory body handles the approval of the device and the drug separately, which complicates the approval process and requires alignment between multiple regulatory agencies. This suggests there may be confusion among marketing application holders due to inconsistent recognition of the device components of combination drugs. These overlapping regulatory frameworks often create challenges in ensuring that both the device and the drug are compliant before they can be marketed.
• Growing Demand for Biologic Drugs is a significant driver for the Auto-Injectors Market Growth
One of the primary drivers of the auto-injector market is the development of biologics, such as vaccines, antibody-drug conjugates, and monoclonal antibodies, which are frequently not able to be administered orally due to their complex molecules and exacting administration criteria. When compared to oral drugs, injectable therapies frequently offer a faster onset of action and higher bioavailability. For instance, with a sharp rise in FDA approvals, 2024 has already shown to be a pivotal year for the biologics industry. The growing use of biologic drugs, especially for the treatment of autoimmune diseases like psoriasis, and Crohn’s disease is expected to increase demand for devices that can efficiently administer these therapies.
Purchase this Premium Report: https://www.industryarc.com/reports/request-quote?id=508399
Key Opportunity Analysis:
Shift Toward Home-Based Healthcare
As healthcare trends move toward home-based care, self-administered treatments are becoming more desirable. Home-based healthcare encourages patients to take more control of their treatment regimens. Autoinjectors, which are designed for easy use by patients themselves, enable individuals to administer injections without requiring a healthcare professional’s assistance. As more patients seek self-management of their chronic conditions like diabetes, rheumatoid arthritis, and asthma, the demand for user-friendly autoinjectors is expected to rise.
Advancements in Auto-injector Technology
Patients prefer autoinjectors that are simple to use, handy to store, effective and safe in therapy, and reasonably priced. Continuous improvements in autoinjector technology benefit a wide range of stakeholders by decreasing the need for time-consuming and costly clinic and hospital visits. As a result, the demand and acceptability of novel autoinjectors are rapidly increasing among patients, caregivers, advocacy groups, physicians, and cost-conscious insurance companies. Furthermore, autoinjectors have lower patient-to-patient and intra-patient dosage variability than oral or nasal methods of delivery, ensuring the correct dose is obtained.
Ongoing technological improvements, such as the development of connected autoinjectors (smart devices) and product launches with differentiating features, provide opportunities for better patient monitoring and adherence. This progress is expected to drive market growth during the forecast period by increasing the adoption of auto-injectors in diverse therapeutic areas.
Support- If you have any questions, please feel free to contact our experts at: https://connect.industryarc.com/lite/schedule-a-call-with-our-sales-expert
The Report also Covers the Following Areas:
• Auto-Injectors Market Size and Forecast
• Auto-Injectors Market Trends
• Auto-Injectors Market Analysis by Type
Auto-Injectors Market 2024-2030: Key Highlights
• CAGR of the market during the forecast period 2024-2030
• Value Chain analysis of key stakeholders
• Detailed analysis of market drivers and opportunities during the forecast period
• Auto-Injectors market size estimation and forecast
• Analysis and predictions on end users’ behavior and upcoming trends
• Competitive landscape and Vendor market analysis including offerings, developments, and financials
• Comprehensive analysis of challenges and constraints in the Auto-Injectors Market
Covid and Ukrainian Crisis Impact:
• The COVID-19 pandemic has caused significant disruptions in global supply chains which has impacted the availability and cost of raw materials as well as the transportation of finished products. This has resulted in increased lead times, reduced production, and higher costs. Additionally, the pandemic has caused delays in investment in new capacity and infrastructure which could impact the long-term supply and demand dynamics in the market.
• The Ukraine and Russia conflict led to an increase in prices and reduction in production which further led to a shortage of Wearable Robot Technology Trend. Many companies have shut business in Russia; temporarily shutting down their plants in Ukraine. Additionally, the crisis in Ukraine has also led to a reduction in investments in the Auto-Injectors market as companies are hesitant to invest in a region that is facing political and economic instability. This could impact the long-term supply and demand dynamics of the market.
To Get a Customized Industry Analysis, Speak with our Research Analyst: https://connect.industryarc.com/lite/schedule-a-call-with-our-sales-expert
List of Top Companies in the Auto-Injectors Market:
The Global Auto-Injectors Market is highly concentrated as the majority share is held by the leading Auto-Injectors providers. The key companies profiled are listed below:
• AbbVie, Inc.
• Sanofi
• Novartis
• Teva Pharmaceutical
• Amgen
• Eli Lilly and Company
• Biogen Idec
• Becton, Dickinson and Company
• AstraZeneca
• Viatris Inc. (Mylan N.V.)
Related Reports:
Injectable Drug Delivery Market - The Injectable Drug Delivery Market is projected to grow at a CAGR of 8.4% by 2030. Due to its efficient and focused drug release and low body side effects, the global drug delivery industry is being driven primarily by the rising incidence of chronic diseases like cancer worldwide.
Subcutaneous Injector Market - The Subcutaneous Injector Market is projected to grow at an estimated CAGR of 8.02% driven by the rising prevalence of chronic diseases, advancements in drug delivery systems, and increasing demand for self-administration therapies.
About IndustryARC™:
IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.
IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.
Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: [email protected]
USA: (+1) 518-282-4727
Web: https://www.industryarc.com
Follow us on: LinkedIn | Facebook | Twitter